Retinitis: Clinical Trials

10 trials for Retinitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 10 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 7, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 21Active not recruiting 1

Follow Retinitis: new trials by email Literature Review of Retinitis trials Research Report on Retinitis

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
QR-1123, Sham procedure - Autosomal Dominant Retinitis Pigmentosa, Eye Diseases
Phase 1 / Phase 2Active not recruitingProQR Therapeutics112019-10-072022-05-06
Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome
Phase 1TerminatedTehran University of Medical Sciences52007-12-012015-11-10
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)252021-11-04
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
Foscarnet sodium - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)532021-11-03
A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)382021-10-27
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)482021-11-03
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
Foscarnet sodium, Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302021-11-04
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Aldesleukin - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedChiron Corporation2005-06-24
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
Cidofovir, Probenecid - Cytomegalovirus Infections, Cytomegalovirus Retinitis
Phase 1WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2021-10-29
A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis
Sevirumab - Cytomegalovirus Retinitis, HIV Infections
Phase 1CompletedSandoz2005-06-24

Narrower conditions

Cytomegalovirus Retinitis (8)  ·  HIV Infections (8)  ·  Acquired Immunodeficiency Syndrome (7)  ·  Cytomegalovirus Infections (6)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (6)  ·  AIDS-Related Opportunistic Infections (5)  ·  Behcet Syndrome (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Multiple Pterygium Syndrome, Autosomal Dominant (1)  ·  Night Blindness, Congenital Stationary, Autosomal Dominant 1 (1)  ·  Papilledema (1)  ·  Retinal Diseases (1)  ·  Retinal Dystrophies (1)

Broader conditions

Eye Diseases (9)  ·  Retinal Diseases (9)  ·  Blood-Borne Infections (8)  ·  Communicable Diseases (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8)  ·  DNA Virus Infections (8)  ·  Eye Infections (8)  ·  Eye Infections, Viral (8)  ·  Genetic Diseases, Inborn (8)  ·  Genital Diseases (8)  ·  Herpesviridae Infections (8)  ·  Immune System Diseases (8)  ·  Immunologic Deficiency Syndromes (8)  ·  Infections (8)  ·  Lentivirus Infections (8)

Interventions

Ganciclovir (4)  ·  Foscarnet (2)  ·  Cidofovir (1)  ·  Probenecid (1)  ·  aldesleukin (1)  ·  sevirumab (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (6)  ·  Chiron Corporation (1)  ·  ProQR Therapeutics (1)  ·  Sandoz (1)  ·  Tehran University of Medical Sciences (1)

Countries

United States (8)  ·  Iran (1)

Top investigators

Behrouz Nikbin, MD (1)  ·  Dankner W (1)  ·  Fereydoun Davatchi, MD (1)  ·  Hardy WD (1)  ·  Holland GN (1)  ·  Hormoz Shams, MD (1)  ·  Jacobson M (1)  ·  Jacobson MA (1)  ·  Polsky B (1)  ·  Spector S (1)

Results publications

PMID 23773637